96 related articles for article (PubMed ID: 9015908)
1. A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.
Murray TS
Br J Clin Pract; 1996; 50(7):368-72. PubMed ID: 9015908
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and tolerability of nisoldipine coat core and hydrochlorothiazide in mild-to-moderate hypertension.
Fodor JG
Int J Clin Pract; 1997; 51(5):271-5. PubMed ID: 9489083
[TBL] [Abstract][Full Text] [Related]
4. Nisoldipine coat-core and heart rate response during treatment of hypertension.
Zannad F
Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nisoldipine and atenolol in the treatment of essential hypertension.
Takahashi H; Fukuyama M; Yoneda S; Okabayashi H; Yoshimura M
Arzneimittelforschung; 1989 Mar; 39(3):379-82. PubMed ID: 2667523
[TBL] [Abstract][Full Text] [Related]
6. A comparison of nisoldipine coat-core and felodipine in the treatment of mild-to-moderate hypertension.
Hoglund C; Hutchinson HG
Int J Clin Pract; 1998 Jun; 52(4):221-5. PubMed ID: 9744143
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical efficacy and adverse effects between extended-release felodipine and atenolol in patients with mild and moderate essential hypertension.
Chern MS; Lin FC; Wu D
Changgeng Yi Xue Za Zhi; 1997 Jun; 20(2):86-93. PubMed ID: 9260367
[TBL] [Abstract][Full Text] [Related]
9. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
Ruddy TD; Fodor JG
Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
[TBL] [Abstract][Full Text] [Related]
10. Nisoldipine CC: clinical experience in hypertension.
Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of tiapamil and atenolol in patients with mild to moderate hypertension: a multicenter trial.
Sykulski R; Keller N; Storm T; Stokke O; Myhre T; Himanen P; Quitzau K
Cardiovasc Drugs Ther; 1989 Jun; 3(3):427-31. PubMed ID: 2487539
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension.
Mettimano M; Pichetti F; Fazzari L; Migneco A; Specchia L; Romano Spica V; Savi L
Int J Clin Pract; 2000 Sep; 54(7):424-8. PubMed ID: 11070565
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nisoldipine and nifedipine as additional treatment in hypertension inadequately controlled by atenolol.
Hoffbrand BI; Earle KA; Nievel JG; Restrick LJ; Simmonds NJ
Postgrad Med J; 1993 Feb; 69(808):117-20. PubMed ID: 8506191
[TBL] [Abstract][Full Text] [Related]
17. [Comparative antihypertensive action of 20 mg delayed-action nifedipine with either 25 or 50 mg atenolol. A study on the treatment of patients with mild to moderately severe arterial hypertension].
Kraft K; Schiessl S; Vetter H
Praxis (Bern 1994); 1996 Sep; 85(36):1081-6. PubMed ID: 8927880
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and tolerability of nifedipine (NIF) and nisoldipine (NIS) both alone and combined with a beta-blocker in patients with essential hypertension: a multicenter, parallel-group study.
Rosenfeld JB; Zabludowski J
J Clin Pharmacol; 1989 Nov; 29(11):1013-6. PubMed ID: 2574728
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
20. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
